Physicochemical characterization, and relaxometry studies of micro-graphite oxide, graphene nanoplatelets, and nanoribbons

PLoS ONE

Volumn 7, Issue 6, 2012, Pages

  Paratala, Bhavna S ^a   Jacobson, Barry D ^a   Kanakia, Shruti ^a   Francis, Leonard Deepak ^b   Sitharaman, Balaji ^a  

^a St Francis Hospital The Heart Center   (United States)

^b INTERNATIONAL IBERIAN NANOTECHNOLOGY LABORATORY   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

CHELATE; GRAPHENE NANOPARTICLE; MANGANESE; NANOPARTICLE; NANOPLATELET; NANORIBBON; PERMANGANATE POTASSIUM; SINGLE WALLED NANOTUBE; UNCLASSIFIED DRUG;

ARTICLE; CHEMICAL STRUCTURE; COMPLEX FORMATION; CONTROLLED STUDY; EXPERIMENTAL STUDY; MAGNETIC FIELD; NANOANALYSIS; NUCLEAR MAGNETIC RESONANCE; PARTICLE SIZE; PHYSICAL CHEMISTRY; PROCESS DEVELOPMENT; SYNTHESIS;

CONTRAST MEDIA; GRAPHITE; MICROSCOPY, ATOMIC FORCE; MICROSCOPY, ELECTRON, SCANNING; MICROSCOPY, ELECTRON, TRANSMISSION; NANOPARTICLES; NANOTUBES, CARBON; OXIDES; PHYSICOCHEMICAL PHENOMENA; SPECTRUM ANALYSIS, RAMAN;

EID: 84862023932     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0038185     Document Type: Article

References (46)

1. Aime S, Botta M, Fasano M, Terreno E, (1998) Lanthanide(iii) chelates for NMR biomedical applications. Chemical Society Reviews 27: 19-29.
2. Caravan P, Elllison JJ, McMurry TJ, Lauffer RB, (1999) Gadolinium(III) chelates as MRI contrast agents: structure, dynamics, and applications. Chem Rev 99: 2293-2352.
3. Lauffer RB, (1987) Paramagnetic metal complexes as water proton relaxation agents for NMR imaging: theory and design. Chem Rev 87: 901-927.
4. Merbach AE, Toth E, (2001) The Chemistry of Contrast Agents in Medical Magnetic Resonance Imaging: John Wiley & Sons.
5. Datta A, Raymond KN, (2009) Gd-Hydroxypyridinone (HOPO)-based high-relaxivity magnetic resonance imaging (MRI) contrast agents. Accounts Chem Res 42: 938-947.
6. Sitharaman B, Wilson LJ, (2007) Gadofullerenes and gadonanotubes: A new paradigm for high-performance magnetic resonance imaging contrast agent probes. Journal of Biomedical Nanotechnology 3: 342-352.
7. Richard C, Doan BT, Beloeil JC, Bessodes M, Tóth É, et al. (2008) Noncovalent functionalization of carbon nanotubes with amphiphilic Gd3+ chelates: toward powerful T1 and T2 MRI contrast agents. Nano Letters 8: 232-236.
8. Manus LM, Mastarone DJ, Waters EA, Zhang XQ, Schultz-Sikma EA, et al. (2009) Gd (III)-nanodiamond conjugates for MRI contrast enhancement. Nano Letters 10: 484-489.
9. Toth E, Bolskar RD, Borel A, Gonzalez G, Helm L, et al. (2005) Water-soluble gadofullerenes: Toward high-relaxivity, pH-responsive MRI contrast agents. J Am Chem Soc 127: 799-805.
10. Kato H, Kanazawa Y, Okumura M, Taninaka A, Yokawa T, et al. (2003) Lanthanoid endohedral metallofullerenols for MRI contrast agents. J Am Chem Soc 125: 4391-4397.
11. Fatouros PP, Corwin FD, Chen ZJ, Broaddus WC, Tatum JL, et al. (2006) In vitro and in vivo imaging studies of a new endohedral metallofullerene nanoparticle. Radiology 240: 756-764.
12. Sitharaman B, Kissell KR, Hartman KB, Tran LA, Baikalov A, et al. (2005) Superparamagnetic gadonanotubes are high-performance MRI contrast agents. Chem Commun pp. 3915-3917.
13. Ananta JS, Godin B, Sethi R, Moriggi L, Liu X, et al. (2010) Geometrical confinement of gadolinium-based contrast agents in nanoporous particles enhances T1 contrast. Nature nanotechnology 5: 815-821.
14. Bresinska I, Balkus KJJ, (1994) Studies of Gd(III)-exchanged Y-type zeolites relevant to magnetic resonance imaging. J Phys Chem 98: 12989-12994.
15. Novoselov KS, Geim AK, Morozov SV, Jiang D, Zhang Y, et al. (2004) Electric field effect in atomically thin carbon films. Science 306: 666.
16. Makarova T, (2004) Magnetic properties of carbon structures. Semiconductors 38: 615-638.
17. Wang Y, Huang Y, Song Y, Zhang X, Ma Y, et al. (2008) Room-temperature ferromagnetism of graphene. Nano Letters 9: 220-224.
18. Stankovich S, Dikin D, Piner R, Kohlhaas K, Kleinhammes A, et al. (2007) Synthesis of graphene-based nanosheets via chemical reduction of exfoliated graphite oxide. Carbon 45: 1558-1565.
19. Kosynkin D, Higginbotham A, Sinitskii A, Lomeda J, Dimiev A, et al. (2009) Longitudinal unzipping of carbon nanotubes to form graphene nanoribbons. Nature 458: 872-876.
20. Hummers W Jr, Offeman R, (1958) Preparation of graphitic oxide. Journal of the American Chemical Society 80: 1339-1339.
21. Geng Y, Wang S, Kim J, (2009) Preparation of graphite nanoplatelets and graphene sheets. Journal of colloid and interface science 336: 592-598.
22. Higginbotham A, Kosynkin D, Sinitskii A, Sun Z, Tour J, (2010) Lower-defect graphene oxide nanoribbons from multiwalled carbon nanotubes. ACS nano 4: 2059-2069.
23. Whitney T, Searson P, Jiang J, Chien C, (1993) Fabrication and magnetic properties of arrays of metallic nanowires. Science (New York, NY) 261: 1316.
24. Wang J, Chen Q, Zeng C, Hou B, (2004) Magnetic field induced growth of single crystalline Fe3O4 nanowires. Advanced Materials 16: 137-140.
25. Du J, Gao Y, Chai L, Zou G, Li Y, et al. (2006) Hausmannite Mn3O4 nanorods: synthesis, characterization and magnetic properties. Nanotechnology 17: 4923.
26. Esquinazi P, Setzer RH A, Semmelhack C, (2002) Ferromagnetism in oriented graphite samples. Physical Review B 66: 024429.
27. Zhou Z, Luo S, Wang Y, Ai Z, Liu C, et al. (2010) Room temperature ferromagnetism and hopping transport in amorphous CrN thin films. Thin Solid Films.
28. Bie X, Wang C, Ehrenberg H, Wei Y, Chen G, et al. (2010) Room-temperature ferromagnetism in pure ZnO nanoflowers. Solid State Sciences 12: 1364-1367.
29. Raley JA, Yeo YK, Hengehold RL, Ryu MY, Steiner TD, (2006) Room temperature ferromagnetic properties of transition metal implanted Al0. 35 Ga0. 65N. Journal of alloys and compounds 423: 184-187.
30. Sigma- Aldrich I Certificate of Analysis- MWCNT.
31. Schoenhalz A, Arantes J, Fazzio A, Dalpian G, (2009) Surface magnetization in non-doped ZnO nanostructures. Applied Physics Letters 94: 162503.
32. Kundaliya DC, Ogale S, Lofland S, Dhar S, Metting C, et al. (2004) On the origin of high-temperature ferromagnetism in the low-temperature-processed Mn-Zn-O system. Nature materials 3: 709-714.
33. Rao SS, Stesmans A, Kosynkin DV, Higginbotham A, Tour JM, (2011) Paramagnetic centers in graphene nanoribbons prepared from longitudinal unzipping of carbon nanotubes. New J Phys 13: 113004.
34. Rohrer M, Bauer H, Mintorovitch J, Requardt M, Weinmann H-J, (2005) Comparison of magnetic Properties of MRI contrast media solutions at different magnetic field strengths. Investigative Radiology 40: 715-724.
35. Laurent S, Forge D, Port M, Roch A, Robic C, et al. (2008) Magnetic iron oxide nanoparticles: synthesis, stabilization, vectorization, physicochemical characterizations, and biological applications. Chemical Reviews 108: 2064-2110.
36. Sur SK, Bryant RG, (1995) Spin-lattice relaxation enhancement of water protons by manganese porphyrins complexed with cyclodextrins. J Phys Chem 99: 4900-4905.
37. Aime S, Anelli P, Botta M, Brocchetta M, Canton S, et al. (2002) Relaxometric evaluation of novel manganese (II) complexes for application as contrast agents in magnetic resonance imaging. Journal of Biological Inorganic Chemistry 7: 58-67.
38. Mao Y, Zhong J, (2008) Structural, electronic and magnetic properties of manganese doping in the upper layer of bilayer graphene. Nanotechnology 19: 205708.
39. Hak S, Sanders HMHF, Agrawal P, Langereis S, Grüll H, et al. (2009) A high relaxivity Gd(III)DOTA-DSPE-based liposomal contrast agent for magnetic resonance imaging. European Journal of Pharmaceutics and Biopharmaceutics 72: 397-404.
40. Swift TJ, Connick RE, (1962) NMR-relaxation mechanisms of O17 in aqueous solutions of paramagnetic cations and the lifetime of water molecules in the first coordination sphere. J Chem Phys 37: 307.
41. Troughton JS, Greenfield MT, Greenwood JM, Dumas S, Wiethoff AJ, et al. (2004) Synthesis and evaluation of a high relaxivity manganese(II)-based MRI contrast agent. Inorg Chem 43: 6313-6323.
42. Caravan P, Farrar CT, Frullano L, Uppal R, (2009) Influence of molecular parameters and increasing magnetic field strength on relaxivity of gadolinium- and manganese-based T1 contrast agents. Contrast Media Mol Imaging 4: 89-100.
43. (2011) Imaging Agents. Global Industry Analysts, Inc:http://www.strategyr.com/Imaging_Agents_Market_Report.asp.
44. US FDA Information on gadolinium- containing contrast agents 2008,http://wwwfdagov/cder/drug/infopage/gcca/.
45. Pan D, Caruthers S, Senpan A, Schmieder A, Wickline S, et al. (2010) Revisiting an old friend: manganese based MRI contrast agents. Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology.
46. Bryant LH, Brechbiel MW, Wu C, Bulte JWM, Herynek V, et al. (1999) Synthesis and relaxometry of high-generation (G = 5, 7, 9, and 10) PAMAM dendrimer-DOTA-gadolinium chelates. Journal of Magnetic Resonance Imaging 9: 348-352.